1;Vorwort;5 2;Inhaltsverzeichnis;7 3;Herausgeber- und Autorenverzeichnis;8 4;1 Umgang mit Medikamenten in der Pflegepraxis;10 5;2 Medikamentenprofile - alphabetisch nach Substanzname;18 5.1;Abemaciclib (T);19 5.2;Abirateron (T);20 5.3;Acalabrutinib (T);21 5.4;Afatinib (T);22 5.5;Aflibercept (T);23 5.6;Alectinib (T);24 5.7;Alemtuzumab (T);25 5.8;All-trans-Retinsäure (T);26 5.9;Alpelisib (T);28 5.10;Amsacrin (T);29 5.11;Anagrelid (T);30 5.12;Anastrozol (T);31 5.13;Apalutamid (T);31 5.14;Arsentrioxid (T);32 5.15;Asparaginase (T);33 5.16;Atezolizumab (T);34 5.17;Avelumab (T);36 5.18;Axicabtagene ciloleucel (T);37 5.19;Axitinib (T);40 5.20;Azacitidin (T);41 5.21;Bendamustin (T);42 5.22;Bevacizumab (T);43 5.23;Bicalutamid (T);45 5.24;Binimetinib (T);45 5.25;Bleomycin (T);47 5.26;Blinatumomab (T);48 5.27;Bortezomib (T);50 5.28;Bosutinib (T);51 5.29;Brentuximab Vedotin (T);53 5.30;Brigatinib (T);54 5.31;Buserelin (T);56 5.32;Busulfan (T);57 5.33;Cabazitaxel (T);57 5.34;Cabozantinib (T);59 5.35;Calciumfolinat (T)/(S);61 5.36;Capecitabin (T);62 5.37;Caplacizumab (S);63 5.38;Capmatinib (T);64 5.39;Carboplatin (T);65 5.40;Carfilzomib (T);66 5.41;Carmustin (T);68 5.42;Cemiplimab (T);69 5.43;Ceritinib (T);71 5.44;Cetuximab (T);72 5.45;Chlorambucil (T);74 5.46;Chlormethin (T);75 5.47;Cisplatin (T);76 5.48;Cladribin (T);78 5.49;Clodronsäure (S);79 5.50;Cobimetinib (T);81 5.51;Crizotinib (T);82 5.52;Cyclophosphamid (T);83 5.53;Cyproteron (T);84 5.54;Cytarabin (T);85 5.55;Dabrafenib (T);87 5.56;Dacarbazin (T);88 5.57;Dacomitinib (T);89 5.58;Dactinomycin (T);90 5.59;Daratumumab (T);92 5.60;Darbepoetin alfa (S);94 5.61;Darolutamid (T);94 5.62;Dasatinib (T);95 5.63;Daunorubicin (T);96 5.64;Daunorubicin/Cytarabin liposomal (T);98 5.65;Decitabin (T);99 5.66;Degarelix (T);100 5.67;Denosumab (S);101 5.68;Dexrazoxan (S);102 5.69;Docetaxel (T);104 5.70;Doxorubicin (T);105 5.71;Doxorubicin liposomal (T);107 5.72;Durvalumab (T);109 5.73;Duvelisib (T);110 5.74;Elotuzumab (T);112 5.75;Eltrombopag (S);113 5.76;Enasidenib (T);115 5.77;Encorafenib (T);116 5.78;Entrectinib (T);117 5.79;Enzalutamid (T);118 5.80;Epirubicin (T);119 5.81;Erdafitinib (T);120 5.82;Eribulin (T);121 5.83;Erlotinib (T);122 5.84;Erythropoetin (S);124 5.85;Estramustin (T);125 5.86;Etoposid (T);125 5.87;Etoposidphosphat (T);126 5.88;Everolimus (T);128 5.89;Exemestan (T);129 5.90;Filgrastim (S);130 5.91;Fludarabin (T);131 5.92;5-Fluorouracil (T);132 5.93;5-Fluorouracil, topisch (T);133 5.94;Fulvestrant (T);134 5.95;Gefitinib (T);135 5.96;Gemcitabin (T);136 5.97;Gemtuzumab Ozogamicin (T);137 5.98;Gilteritinib (T);139 5.99;Glasdegib (T);140 5.100;Goserelin (T);141 5.101;Hydroxyurea (T);142 5.102;Ibandronsäure (S);143 5.103;Ibritumomab tiuxetan (T);144 5.104;zMaßnahmen bei Extravasation;145 5.105;Ibrutinib (T);146 5.106;Idarubicin (T);147 5.107;Idelalisib (T);149 5.108;Ifosfamid (T);150 5.109;Imatinib (T);151 5.110;Imiquimod (T);153 5.111;Inotuzumab Ozogamicin (T);154 5.112;Interferon alfa-2a (T);155 5.113;Interferon alfa-2b (T);156 5.114;Ipilimumab (T);158 5.115;Irinotecan (T);160 5.116;Irinotecan liposomal (T);161 5.117;Ivosidenib (T);162 5.118;Ixazomib (T);163 5.119;Lanreotid (T)/(S);164 5.120;Lapatinib (T);165 5.121;Larotrectinib (T);166 5.122;Lenalidomid (T);167 5.123;Lenograstim (S);168 5.124;Lenvatinib (T);169 5.125;Letrozol (T);171 5.126;Leuprorelin (T);171 5.127;Lipegfilgrastim (S);172 5.128;Lomustin (T);173 5.129;Lorlatinib (T);174 5.130;Luspatercept (T);174 5.131;Lutetium (177Lu)-Oxodotreotid (T);175 5.132;Medroxyprogesteron (T);176 5.133;Megestrolacetat (T);177 5.134;Melphalan (T);178 5.135;Mercaptopurin (T);179 5.136;Mesna (S);180 5.137;Methotrexat (T);181 5.138;Midostaurin (T);183 5.139;Mifamurtid (T);184 5.140;Mitomycin (T);185 5.141;Mitotan (T);186 5.142;Mitoxantron (T);187 5.143;Mogamulizumab (T);188 5.144;Moxetumomab pasudotox-tdfk (T);190 5.145;Necitumumab (T);192 5.146;Nelarabin (T);193 5.147;Neratinib (T);194 5.148;Nilotinib (T);195 5.149;Nintedanib (T);197 5.150;Niraparib